Atlas Trials

The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality

Clinical trial NCT00874978 · COMPLETED

Trial details

NCT number
NCT00874978
Sponsor
King's College Hospital NHS Trust
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2005-01-01
Primary completion
2016-05-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.